Glaxosmithkline Pharmaceuticals informs about compliance certificate

08 Apr 2020 Evaluate

Glaxosmithkline Pharmaceuticals has informed that in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, the Company enclosed a copy of the Certificate received from KFin Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2020.

The above information is a part of company’s filings submitted to BSE. 

Glaxosmithkline Phar Share Price

2334.90 26.90 (1.17%)
25-Mar-2026 09:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1772.20
Dr. Reddys Lab 1279.60
Cipla 1227.95
Zydus Lifesciences 896.55
Lupin 2342.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×